https://journals.uran.ua/sr_med/issue/feedScienceRise: Medical Science2025-12-17T22:15:35+02:00Yuliia Nikolaievamed@entc.com.uaOpen Journal Systems<p style="font-weight: 400;"><em>"ScienceRise: Medical Science" </em>is a peer-reviewed scientific journal published 4 times a year.</p> <p style="font-weight: 400;">ScienceRise: Medical Science primarily publishes original research and clinical cases, but also accepts high-quality literature reviews and meta-analyses for publication. Short notices, short reviews, reports and messages are not published in the journal.</p> <p style="font-weight: 400;">The subject matter of the journal covers the areas of research devoted to treatment technologies, in particular, under conditions when the possibilities of decision-making regarding the treatment strategy are limited by insufficient sampling of diagnostic data, conditions for conducting long-term studies of chronic processes, the absence of conditions that would allow obtaining a sufficient volume of data sampling to determine adequate and effective treatment strategy. Related diagnostic problems are also considered.</p> <p style="font-weight: 400;">The journal is accredited by the Ministry of Health of Ukraine in the field of medical sciences and is recommended for publishing the results of dissertation research. <a href="http://nfv.ukrintei.ua/view/5b1925e37847426a2d0ab7e7">Included in the "B" category of the "List of Professional Publications of Ukraine"</a> (order of the Ministry of Education and Culture of Ukraine No. 612 of 07.05.2019).</p> <p>Registration of an entity in the media sector: Decision of the National Council of Ukraine on Television and Radio Broadcasting No. 695 dated August 10, 2023, protocol No. 17 (media identifier R30-01132).</p> <p style="font-weight: 400;">The journal is international, accredited by CrossRef and COPE and indexed by world resources of scientific periodicals.</p> <p><a href="https://portal.issn.org/resource/ISSN/2519-478X">ISSN 2519-478X</a>, <a href="https://portal.issn.org/resource/ISSN/2519-4798ISSN">E-ISSN 2519-4798</a>, <a href="https://portal.issn.org/resource/ISSN/2519-478X">ISSN-L 2519-478X</a><br /><br />Drawing up the items of the publication ethics policy of the journal «ScienceRise: Medical Science» Editors followed the recommendations of Committee on Publication Ethics <a href="http://publicationethics.org/">(COPE)</a>.</p>https://journals.uran.ua/sr_med/article/view/346733Endoscopic forehead lift in combination with botulinum therapy and fillers: analysis of efficacy and safety2025-12-16T10:59:31+02:00Nelli Pankovetsnpankovets1@gmail.com<p><strong>The aim: </strong>Upper facial aging significantly impacts self-perception and quality of life as changes become apparent in the forehead, glabellar complex, and brow positioning. This narrative literature review evaluates clinical efficacy, safety profile and aesthetic outcomes of 3 treatment options: endoscopic forehead lift, botulinum toxin A and hyaluronic acid injectable dermal fillers, examining their individual and combined applications.</p> <p><strong>Materials and methods: </strong>Literature was obtained between April and August 2025 from electronic databases: PubMed, ScienceDirect, Google Scholar, Nature, Wiley Online Library, ResearchGate, Springer and Clinical key; using targeted search strategies. Inclusion criteria encompassed articles discussing these interventions in human participants published between 2000-2025. Exclusion criteria included mid-/lower face procedures, animal studies and non-peer reviewed editorials. Forty-one sources were selected based on clinical relevance and methodological quality.</p> <p><strong>Results: </strong>Endoscopic forehead lift demonstrated 93% patient satisfaction with superior long term structural repositioning. BoNT-A provided effective dynamic wrinkle reduction lasting 3-6 months with minimal complications. Hyaluronic acid fillers addressed volumetric deficits and static wrinkles lasting 6-18 months. Combined BoNT-A with HA fillers showed significantly enhanced outcomes, with 84.15% patient satisfaction at 6 months versus 55.12% with botulinum toxin A monotherapy. All modalities demonstrated excellent safety profiles with complications under 3%.</p> <p><strong>Conclusions: </strong>Multimodal rejuvenation addressing multiple aging mechanisms simultaneously results in superior aesthetic outcomes and patient satisfaction compared to single modality procedures. Substantial evidence gaps exist regarding optimal sequencing and long-term outcomes of combined surgical-injectable approaches. Future prospective studies examining endoscopic procedures with injectable modalities across diverse populations are essential to establish evidence-based clinical protocols</p>2025-12-17T00:00:00+02:00Copyright (c) 2025 Nelli Pankovets